| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,870 |
7,434 |
$291K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,743 |
4,106 |
$140K |
| 99215 |
Prolong outpt/office vis |
704 |
561 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,263 |
1,597 |
$18K |
| 99233 |
Prolong inpt eval add15 m |
1,736 |
250 |
$17K |
| Q3014 |
Telehealth originating site facility fee |
1,647 |
1,155 |
$15K |
| 80305 |
|
3,371 |
2,912 |
$13K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
82 |
79 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
90 |
72 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
267 |
184 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,502 |
2,172 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
160 |
116 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
114 |
66 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
267 |
184 |
$2K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
14 |
13 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
916 |
629 |
$802.76 |
| 99442 |
|
54 |
47 |
$760.85 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
13 |
$740.46 |
| 81000 |
|
266 |
206 |
$307.50 |
| 90682 |
|
34 |
31 |
$301.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
13 |
$220.43 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
19 |
12 |
$163.90 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
51 |
37 |
$101.37 |
| 86580 |
|
69 |
61 |
$82.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
44 |
35 |
$71.66 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
204 |
163 |
$57.64 |
| G0008 |
Administration of influenza virus vaccine |
54 |
46 |
$35.03 |
| 86850 |
|
41 |
36 |
$31.65 |
| 81003 |
|
27 |
25 |
$11.55 |